Close Menu
    Facebook X (Twitter) Instagram Pinterest YouTube LinkedIn TikTok
    TopBuzzMagazine.com
    Facebook X (Twitter) Instagram Pinterest YouTube LinkedIn TikTok
    • Home
    • Movies
    • Television
    • Music
    • Fashion
    • Books
    • Science
    • Technology
    • Cover Story
    • Contact
      • About
      • Amazon Disclaimer
      • Terms and Conditions
      • Privacy Policy
      • DMCA / Copyrights Disclaimer
    TopBuzzMagazine.com
    Home»Science»Gut microbiome may alter response to cancer therapy
    Science

    Gut microbiome may alter response to cancer therapy

    By AdminJuly 2, 2022
    Facebook Twitter Pinterest LinkedIn Tumblr Email

    Since ancient times, our gut microbiome, home to a vast number of bacteria, viruses, fungi, and other microorganisms, has been thought to influence many aspects of human health. Most recently, sequencing technology has shown that it may also play a role in the treatment of cancer. A review paper published in JAMA Oncology by investigators from Brigham and Women’s Hospital captures the current understanding of the connection between the gut microbiome and therapeutic response to immunotherapy, chemotherapy, cancer surgery and more, pointing to ways that the microbiome could be targeted to improve treatment.

    “We know that a healthy gut is key to our overall health,” said lead author Khalid Shah, MS, PhD, of the Center for Stem Cell and Translational Immunotherapy in the Department of Neurosurgery at the Brigham. “Our gut is so important that we often refer to it as our ‘second’ brain. In recent years, we’ve begun to appreciate the many roles of the gut, including the gut-brain connection and the connection between the gut and our immune system. Conversely, gut dysfunction or dysbiosis can have a negative effect on our health.”

    Shah and colleagues report on an emerging role for gut microbiota in immunotherapy. Immune checkpoint inhibitors and immune checkpoint blockade therapy are novel strategies for treating cancer, but response to these forms of treatment varies considerably between individuals and across cancer types. Several studies have found differences in the species of bacteria found in fecal samples from responders and non-responders, suggesting that different microbiome compositions may influence clinical responses. Other studies suggest that diet and probiotics — live bacterial species that can be ingested — as well as antibiotic medications and bacteriophages can influence the composition of the gut microbiome and, in turn, a response to immunotherapy. In particular, the authors highlight recent studies on the effects of ketogenic diets for patients with cancer.

    “Today, developing treatments that sync immunotherapies and gut microbiota provides medicine a unique opportunity to truly effect change in patient care,” said Shah.

    The authors also provide an overview of how microbiota have been implicated in influencing response to chemotherapy and other conventional cancer treatments as well as how cancer therapies may reciprocally affect the microbiome and cause side effects.

    “Overall, these findings support the potential of influencing the gut microbiota to diminish the side effects of conventional cancer treatment,” said Shah.

    The authors note that there is little understanding of what the “ideal” bacteria consortia in the gut looks like and how findings from preclinical models may or may not translate into applications in humans. They note that caution must be exercised before using probiotics or making dietary changes. Many cancer clinical trials are currently exploring the influence of the microbiome to help address some of the limitations and gaps in understanding. These include trials of fecal microbial transplantation, dietary supplements and novel drugs that may influence microbiota composition.

    “There is strong evidence that the gut microbiome can have a positive influence on cancer therapies,” said Shah. “There remain exciting possibilities to explore, including the influence of healthy diet, probiotics, novel therapies, and more.”

    Disclosures: Shah owns equity in and is a member of the Board of Directors of AMASA Therapeutics, a company developing stem cell-based therapies for cancer; Shah’s interests were reviewed and are managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with conflict-of-interest policies. No other disclosures were reported.

    Story Source:

    Materials provided by Brigham and Women’s Hospital. Note: Content may be edited for style and length.

    Read The Full Article Here

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Herpes virus could soon be approved to treat severe skin cancer

    July 9, 2025

    Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

    July 8, 2025

    Melting glaciers could trigger volcanic eruptions around the globe, study finds

    July 8, 2025

    Vapour-sniffing drug detector tested at the US-Mexico border

    July 7, 2025

    Dark dwarfs lurking at the center of our galaxy might hint at the nature of dark matter

    July 7, 2025

    What did ancient Rome smell like? BO, rotting corpses and raw sewage for starters …

    July 6, 2025
    popular posts

    The Top New Features in Apple’s iOS and iPadOS 16

    Valak Is Back in ‘The Nun II’ Trailer

    Amazon Accused of Violating US Labour Law After Union Supporters’

    Electric Planes Take Off

    A brain network for social attraction: Specialized nerve cells in

    Days of Our Lives Spoilers For The Week of 1-20-25 Promise A Love Triangle Everyone Saw Coming

    How to Host an Outdoor Viewing Party

    Categories
    • Books (3,276)
    • Cover Story (4)
    • Events (18)
    • Fashion (2,441)
    • Interviews (43)
    • Movies (2,575)
    • Music (2,853)
    • News (155)
    • Politics (1)
    • Science (4,425)
    • Technology (2,568)
    • Television (3,298)
    • Uncategorized (932)
    Archives
    Facebook X (Twitter) Instagram Pinterest YouTube Reddit TikTok
    © 2025 Top Buzz Magazine. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms of Use and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Do not sell my personal information.
    Cookie SettingsAccept
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT